Skip to content

Adma Biologics, Inc.

ADMA· NasdaqCore metricsCIK 1368514

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · +0.34%
Market cap
$2.94B
221.85M shares
Filings
1,004
$141.10M
Q3 2026+19.6% FY25 yoy
$49.88M
Q3 2026−25.7% FY25 yoy
$67.76M
Q3 2026+37.7% FY25 yoy
$98.36M
Q3 2026derived−74.8% FY25 yoy
$0.22
Q3 2026−25.9% FY25 yoy
$124.56M
Q3 2026−15.0% FY25 yoy
$2.94B
16.1×
5.7×
6.7×
4.53%
—

Twelve months to Sep 30, 2026 · derived

Price

$13.2417.59%$2.82past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$510.17MFY 2025
$510.17M0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$510,173,000reported
FY 20242024-12-31$426,454,000reported
FY 20232023-12-31$258,215,000reported
FY 20222022-12-31$154,080,000reported
FY 20212021-12-31$80,943,000reported
FY 20202020-12-31$42,219,783reported
FY 20192019-12-31$29,349,083reported
FY 20182018-12-31$16,985,290reported
FY 20172017-12-31$22,760,560reported
FY 20162016-12-31$10,661,037reported
FY 20152015-12-31$7,177,633reported
FY 20142014-12-31$5,915,545reported

Capital returns

Dividends and buybacks · FY2011 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025—$31.94M$31.94M—238.16M sh+0.2%114.8%
FY2024—$0.00$0.00—237.62M sh+4.1%0.0%
FY2023—$0.00$0.00—228.22M sh+2.7%0.0%
FY2012—$150.00K$150.00K—4.62M sh+1,031.4%—
FY2011—$0.00$0.00—408.59K sh——

Segments

Revenue by Segments, FY2020 to FY2025FY2020ADMA BioManufacturing · FY2020 · $36.67MPlasma Collection Centers · FY2020 · $5.40MCorporate · FY2020 · $142.83KFY2021ADMA BioManufacturing · FY2021 · $74.94MPlasma Collection Centers · FY2021 · $5.86MCorporate · FY2021 · $143.00KFY2022ADMA BioManufacturing · FY2022 · $144.07MPlasma Collection Centers · FY2022 · $9.87MCorporate · FY2022 · $143.00KFY2023ADMA BioManufacturing · FY2023 · $249.74MPlasma Collection Centers · FY2023 · $8.33MCorporate · FY2023 · $143.00KFY2024ADMA BioManufacturing · FY2024 · $415.81MPlasma Collection Centers · FY2024 · $10.51MFY2025ADMA BioManufacturing · FY2025 · $493.00MPlasma Collection Centers · FY2025 · $17.03M
LineFY2025ShareChange
ADMA BioManufacturing$493.00M97%+18.6%
Plasma Collection Centers$17.03M3.3%+62.1%
Corporate———
Total$510.17M

From the 10-K filed Feb 25, 2026ADMA

Biological products, except diagnostic substances

Adma Biologics, Inc. is the 14th largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Adma Biologics, Inc. · CIK 1368514 · Engraved from SEC EDGAR